Zentiva Group announces acquisition of UK based Creo Pharmaceuticals

Zentiva Group announces the acquisition of Creo Pharmaceuticals Ltd, a UK based company, a subsidiary of Amneal Pharmaceuticals. “We are excited to announce the acquisition of Creo Pharma, which will strengthen Zentiva’s position in the UK. The decision reflects confidence in this market and our firm commitment to the development, production and distribution of affordable, high-quality medicines. We welcome Creo Pharma team and its solid ...

Developed by Codecraftsman